Evaluation of the safety and efficacy of tocilizumab (AryoGen ?Pharmed Co., Iran) in patients with severe COVID-19
Latest Information Update: 31 Jul 2020
At a glance
- Drugs Tocilizumab (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Sponsors AryoGen Pharmed
- 31 Jul 2020 New trial record